Newfound Research »

BioMarin Pharmaceutical shares owned by Newfound Research

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Newfound Research from 13F filings

Historical chart of Newfound Research investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Newfound Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Newfound Research

Quarter filed Position value Share count Share price at filing
2022-09-30 $60k 707 84.87
2020-09-30 $21k 277 75.81

More positions owned by Newfound Research

Ishares 1 3 Yr Tread Bd (SHY)
Vanguard Wellington Us Momentum (VFMO)
Ishares Tr Msci Usa Mmentm (MTUM)
J P Morgan Exchange-traded F Us Momentum (JMOM)
Fidelity Covington Trust Momentum Factr (FDMO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange-traded F Us Qualty Fctr (JQUA)
Fidelity Covington Trust Qlty Fctor Etf (FQAL)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Msci Usa Min Vol (USMV)
Spdr Ser Tr Ssga Us Lrg Etf (LGLV)
Fidelity Covington Trust Low Volity Etf (FDLO)
Select Select Spdr Tr Technology (XLK)
Select Select Spdr Tr Sbi Cons Discr (XLY)

View all positions for Newfound Research

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical